How much dividend does Cochlear pay?
Over the past 12 months, Cochlear paid a dividend of 4.06 AUD . This corresponds to a dividend yield of about 1.2 %. For the coming 12 months, Cochlear is expected to pay a dividend of 4.25 AUD.
Cochlear Dividend 2024
Cochlear Dividend
4.06 AUD
Cochlear Dividend yield
1.2 %
Ticker
COH.AX
ISIN
AU000000COH5
WKN
898321
How much dividend does Cochlear 2024 pay?
According to the latest status from August 2024, Cochlear paid a total of 4.06 AUD per share in dividends within the last 12 months. With the current Cochlear price of 339.01 AUD, this corresponds to a dividend yield of 1.2 %. A dividend is paid 2 times per year.
| 1.2 % Dividend Yield | = |
|
Historical Cochlear Dividends
A dividend is paid 2 times per year. Last year, the payout months were April and October.
| Paydate | Dividend |
|---|---|
| 4/21/2024 | 2.6 |
| 10/18/2023 | 2.28 |
| 4/21/2023 | 1.78 |
| 10/21/2022 | 1.7 |
| 4/28/2022 | 1.55 |
| 10/23/2021 | 1.4 |
| 4/25/2021 | 1.15 |
| 4/24/2020 | 2.29 |
| 10/19/2019 | 2.5 |
| 4/25/2019 | 2.21 |
| 10/17/2018 | 2.29 |
| 4/19/2018 | 2 |
| 10/19/2017 | 2 |
| 4/15/2017 | 1.86 |
| 10/7/2016 | 1.71 |
| 4/10/2016 | 1.57 |
| 10/8/2015 | 1.43 |
| 4/3/2015 | 1.04 |
| 10/2/2014 | 1.38 |
| 3/28/2014 | 1.27 |
1
2
3
Cochlear dividend history and estimates AU000000COH5 · 898321
In 2023, Cochlear paid a dividend amounting to 4.06 AUD. Dividend means that Cochlear distributes a portion of its profits to its owners.
3 years
5 years
10 years
25 Years
Max
Dividend
Dividend (Estimate)
Details
Dividend
ⓘDividend Overview
The dividend per year chart for Cochlear provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
Interpretation and Use
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Cochlear’s potential for long-term investment and income generation through dividends.
Investment Strategy
Incorporate the dividend data in evaluating Cochlear's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
Cochlear Dividend History
| Date | Cochlear Dividend |
|---|---|
| 2030e | 4.26 AUD |
| 2029e | 4.26 AUD |
| 2028e | 4.26 AUD |
| 2027e | 4.27 AUD |
| 2026e | 4.26 AUD |
| 2025e | 4.25 AUD |
| 2024e | 4.29 AUD |
| 2023 | 4.06 AUD |
| 2022 | 3.25 AUD |
| 2021 | 2.55 AUD |
| 2020 | 2.29 AUD |
| 2019 | 4.71 AUD |
| 2018 | 4.29 AUD |
| 2017 | 3.86 AUD |
| 2016 | 3.29 AUD |
| 2015 | 2.46 AUD |
| 2014 | 2.65 AUD |
| 2013 | 2.9 AUD |
| 2012 | 2.95 AUD |
| 2011 | 2.88 AUD |
| 2010 | 2.68 AUD |
| 2009 | 2.5 AUD |
| 2008 | 2.14 AUD |
| 2007 | 1.79 AUD |
| 2006 | 1.43 AUD |
| 2005 | 1.14 AUD |
| 2004 | 1.13 AUD |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2004 | 1.13 AUD | 0 AUD |
| 2005 | 1.14 AUD | 0 AUD |
| 2006 | 1.43 AUD | 0 AUD |
| 2007 | 1.79 AUD | 0 AUD |
| 2008 | 2.14 AUD | 0 AUD |
| 2009 | 2.5 AUD | 0 AUD |
| 2010 | 2.68 AUD | 0 AUD |
| 2011 | 2.88 AUD | 0 AUD |
| 2012 | 2.95 AUD | 0 AUD |
| 2013 | 2.9 AUD | 0 AUD |
| 2014 | 2.65 AUD | 0 AUD |
| 2015 | 2.46 AUD | 0 AUD |
| 2016 | 3.29 AUD | 0 AUD |
| 2017 | 3.86 AUD | 0 AUD |
| 2018 | 4.29 AUD | 0 AUD |
| 2019 | 4.71 AUD | 0 AUD |
| 2020 | 2.29 AUD | 0 AUD |
| 2021 | 2.55 AUD | 0 AUD |
| 2022 | 3.25 AUD | 0 AUD |
| 2023 | 4.06 AUD | 0 AUD |
| 2024e | 0 AUD | 4.29 AUD |
| 2025e | 0 AUD | 4.25 AUD |
| 2026e | 0 AUD | 4.26 AUD |
| 2027e | 0 AUD | 4.27 AUD |
| 2028e | 0 AUD | 4.26 AUD |
| 2029e | 0 AUD | 4.26 AUD |
| 2030e | 0 AUD | 4.26 AUD |
Is the Cochlear Dividend Safe?
Cochlear has been increasing the dividend for 3 years.
Over the past 10 years, Cochlear has increased it by an annual 3.424 %.
Over a five-year period, the distribution increased by -1.088%.
Analysts expect a Dividend Increase of 2.825% for the current fiscal year.
Cochlear dividend payout ratio AU000000COH5 · 898321
In 2023, Cochlear had a payout ratio of 74.52%. The payout ratio indicates the percentage of the company's profits that Cochlear distributes as dividends.
3 years
5 years
10 years
25 Years
Max
Payout ratio
Details
Payout ratio
ⓘWhat is Yearly Payout Ratio?
The yearly payout ratio for Cochlear represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
How to Interpret the Data
A lower payout ratio for Cochlear could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Using the Data for Investments
Evaluate Cochlear's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
Cochlear Payout Ratio History
| Date | Cochlear Payout ratio |
|---|---|
| 2030e | 70.33 % |
| 2029e | 70.48 % |
| 2028e | 70.78 % |
| 2027e | 69.73 % |
| 2026e | 70.93 % |
| 2025e | 71.67 % |
| 2024e | 66.59 % |
| 2023 | 74.52 % |
| 2022 | 73.91 % |
| 2021 | 51.34 % |
| 2020 | -57.2 % |
| 2019 | 98.32 % |
| 2018 | 100.6 % |
| 2017 | 99.12 % |
| 2016 | 99.56 % |
| 2015 | 96.67 % |
| 2014 | 161.52 % |
| 2013 | 124.9 % |
| 2012 | 294.71 % |
| 2011 | 91.14 % |
| 2010 | 97.71 % |
| 2009 | 107.3 % |
| 2008 | 103.52 % |
| 2007 | 99.21 % |
| 2006 | 98.52 % |
| 2005 | 114.29 % |
| 2004 | 165.97 % |
| Payout ratio | |
|---|---|
| 2004 | 165.97 % |
| 2005 | 114.29 % |
| 2006 | 98.52 % |
| 2007 | 99.21 % |
| 2008 | 103.52 % |
| 2009 | 107.3 % |
| 2010 | 97.71 % |
| 2011 | 91.14 % |
| 2012 | 294.71 % |
| 2013 | 124.9 % |
| 2014 | 161.52 % |
| 2015 | 96.67 % |
| 2016 | 99.56 % |
| 2017 | 99.12 % |
| 2018 | 100.6 % |
| 2019 | 98.32 % |
| 2020 | -57.2 % |
| 2021 | 51.34 % |
| 2022 | 73.91 % |
| 2023 | 74.52 % |
| 2024e | 66.59 % |
| 2025e | 71.67 % |
| 2026e | 70.93 % |
| 2027e | 69.73 % |
| 2028e | 70.78 % |
| 2029e | 70.48 % |
| 2030e | 70.33 % |
Dividend Details
Understanding Cochlear's Dividend Distributions
Cochlear’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Cochlear's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Cochlear's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Cochlear’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Cochlear Aktienanalyse
What does Cochlear do?
Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about Cochlear stock
What is the dividend yield of Cochlear?
The current dividend yield of Cochlear is 1.2 %.
When does Cochlear pay dividends?
Cochlear pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Cochlear?
Cochlear paid dividends every year for the past 27 years.
What is the dividend of Cochlear?
For the upcoming 12 months, dividends amounting to 4.25 AUD are expected. This corresponds to a dividend yield of 1.26 %.
In which sector is Cochlear located?
Cochlear is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cochlear kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cochlear from 4/15/2024 amounting to 2.6 AUD, you needed to have the stock in your portfolio before the ex-date on 3/21/2024.
When did Cochlear pay the last dividend?
The last dividend was paid out on 4/15/2024.
What was the dividend of Cochlear in the year 2023?
In the year 2023, Cochlear distributed 3.249 AUD as dividends.
In which currency does Cochlear pay out the dividend?
The dividends of Cochlear are distributed in AUD.
Andere Kennzahlen von Cochlear
Our stock analysis for Cochlear Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cochlear Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
